Clinical Outcomes Improvement Committee

Purpose:
The Clinical Outcomes Improvement Committee assists hematopoietic progenitor cell transplant programs with improving patient outcomes by providing resources, creating tools, and reviewing corrective action plans.

Current members of Clinical Outcomes Improvement Committee:

Position

Name

Organization

City

Country

Chair

Amir Steinberg MD, FACP

Westchester Medical Center, Cancer Center

Valhalla

United States

Member

Luke Akard MD

Indiana Blood and Marrow Transplantation (IBMT)

Indianapolis

United States

Member

Dennis Gastineau MD

El Prado

United States

Member

Samantha M. Jaglowski MD, MPH

The Ohio State University Arthur G. James Cancer Hospital & Richard J. Solove Research Institute

Columbus

United States

Member

C. Fred LeMaistre MD

Nashville

United States

Member

Premal Lulla MD, MBBS

Baylor College of Medicine, Stem Cell Transplant Program, Texas Children's Hospital and Houston Methodist Hospital

Houston

United States

Member

Stephen Medlin DO

Aurora Hematologic Malignancy and Stem Cell Transplant Program

Milwaukee

United States

Member

Eneida Nemecek MD

Northwest Marrow Transplant Program at Oregon Health & Science University, Legacy Good Samaritan Hospital and Medical Center and Doernbecher Children's Hospital

Portland

United States

Member

Ms Andreza Ribeiro

Hospital Israelita Albert Einstein

Sao Paulo

Brazil

Member

George Selby MD

OU Medicine Transplant and Cellular Therapy Program

Oklahoma City

United States

Member

Phyllis I. Warkentin MD

Biologics Production Facility, Nebraska Medicine, The Nebraska Medical Center

Omaha

United States

Staff Liaison

Kara Wacker MBA, RAC

Foundation for the Accreditation of Cellular Therapy

Omaha

United States


Ask FACT

FAQ

As a Matter of FACT

FACT inspectors have free access to all FACT training and educational opportunities.
Ask FACT

FAQ

As a Matter of FACT

FACT inspectors have free access to all FACT training and educational opportunities.